|
1
|
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
|
Chest
|
2009
|
14.06
|
|
2
|
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
|
Chest
|
2010
|
10.29
|
|
3
|
Effect of dronedarone on cardiovascular events in atrial fibrillation.
|
N Engl J Med
|
2009
|
8.51
|
|
4
|
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
|
N Engl J Med
|
2002
|
8.37
|
|
5
|
Lenient versus strict rate control in patients with atrial fibrillation.
|
N Engl J Med
|
2010
|
8.17
|
|
6
|
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
|
N Engl J Med
|
2007
|
5.78
|
|
7
|
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
|
Eur Heart J
|
2005
|
4.46
|
|
8
|
Effects of antidepressant treatment following myocardial infarction.
|
Br J Psychiatry
|
2007
|
4.44
|
|
9
|
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction.
|
Circulation
|
2004
|
3.05
|
|
10
|
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
|
J Am Coll Cardiol
|
2005
|
2.93
|
|
11
|
Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.
|
Eur Heart J
|
2010
|
2.86
|
|
12
|
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?
|
J Mol Med (Berl)
|
2004
|
2.81
|
|
13
|
Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis.
|
J Am Coll Cardiol
|
2010
|
2.59
|
|
14
|
Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study.
|
J Am Coll Cardiol
|
2010
|
2.50
|
|
15
|
Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands.
|
Chest
|
2005
|
2.50
|
|
16
|
Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.
|
Am J Psychiatry
|
2006
|
2.41
|
|
17
|
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy.
|
Circ Res
|
2004
|
2.31
|
|
18
|
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT.
|
Eur Heart J
|
2005
|
2.28
|
|
19
|
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.
|
J Am Coll Cardiol
|
2011
|
2.19
|
|
20
|
Who is at risk of post-MI depressive symptoms?
|
J Psychosom Res
|
2005
|
2.18
|
|
21
|
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
|
J Am Coll Cardiol
|
2009
|
2.16
|
|
22
|
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.
|
J Am Coll Cardiol
|
2004
|
2.10
|
|
23
|
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
|
JAMA
|
2008
|
2.09
|
|
24
|
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
|
J Am Coll Cardiol
|
2013
|
2.08
|
|
25
|
Relation of levels of serum lipoproteins to depression after acute myocardial infarction.
|
Am J Cardiol
|
2002
|
1.92
|
|
26
|
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome.
|
Heart Rhythm
|
2006
|
1.91
|
|
27
|
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects.
|
J Am Coll Cardiol
|
2009
|
1.87
|
|
28
|
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
|
Eur Heart J
|
2006
|
1.84
|
|
29
|
Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes.
|
Gen Hosp Psychiatry
|
2005
|
1.76
|
|
30
|
Acute results of transvenous cryoablation of supraventricular tachycardia (atrial fibrillation, atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal reentry tachycardia).
|
J Cardiovasc Electrophysiol
|
2002
|
1.72
|
|
31
|
Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
|
J Am Coll Cardiol
|
2005
|
1.71
|
|
32
|
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.
|
Am Heart J
|
2005
|
1.71
|
|
33
|
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.
|
Europace
|
2008
|
1.68
|
|
34
|
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
|
Europace
|
2012
|
1.67
|
|
35
|
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
|
Eur Heart J
|
2008
|
1.64
|
|
36
|
Dronedarone for prevention of atrial fibrillation: a dose-ranging study.
|
Eur Heart J
|
2003
|
1.63
|
|
37
|
Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study.
|
Europace
|
2011
|
1.61
|
|
38
|
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients.
|
Eur Heart J
|
2011
|
1.60
|
|
39
|
The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines.
|
Europace
|
2010
|
1.59
|
|
40
|
Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
|
Europace
|
2011
|
1.57
|
|
41
|
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate.
|
J Cardiovasc Electrophysiol
|
2004
|
1.57
|
|
42
|
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey.
|
Eur Heart J
|
2008
|
1.57
|
|
43
|
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome.
|
Heart Rhythm
|
2006
|
1.56
|
|
44
|
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
|
Eur Heart J
|
2004
|
1.54
|
|
45
|
Calculation of effective VV interval facilitates optimization of AV delay and VV interval in cardiac resynchronization therapy.
|
Heart Rhythm
|
2006
|
1.54
|
|
46
|
Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
|
Heart Rhythm
|
2005
|
1.52
|
|
47
|
The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis.
|
Chest
|
2005
|
1.51
|
|
48
|
Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?
|
Eur Heart J
|
2008
|
1.51
|
|
49
|
The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
|
J Am Coll Cardiol
|
2011
|
1.51
|
|
50
|
How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2002
|
1.45
|
|
51
|
Clinical and echocardiographic correlates of intra-atrial conduction delay.
|
Europace
|
2011
|
1.45
|
|
52
|
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
|
Circulation
|
2009
|
1.43
|
|
53
|
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
|
Am Heart J
|
2007
|
1.42
|
|
54
|
RR-interval irregularity precedes ventricular fibrillation in ST elevation acute myocardial infarction.
|
Heart Rhythm
|
2009
|
1.42
|
|
55
|
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
|
Heart Rhythm
|
2005
|
1.42
|
|
56
|
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial.
|
Europace
|
2013
|
1.42
|
|
57
|
Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
|
J Am Coll Cardiol
|
2007
|
1.42
|
|
58
|
Atrial natriuretic peptides during experimental atrial tachycardia: role of developing tachycardiomyopathy.
|
J Cardiovasc Electrophysiol
|
2004
|
1.40
|
|
59
|
Evaluation of the electrocardiogram in identifying and quantifying lateral involvement in nonanterior wall infarction using cardiovascular magnetic resonance imaging.
|
J Electrocardiol
|
2012
|
1.39
|
|
60
|
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
|
Circ Res
|
2004
|
1.39
|
|
61
|
Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion.
|
Eur Heart J
|
2004
|
1.36
|
|
62
|
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis.
|
J Am Coll Cardiol
|
2003
|
1.36
|
|
63
|
Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.
|
J Mol Cell Cardiol
|
2006
|
1.31
|
|
64
|
Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.
|
Eur Heart J
|
2012
|
1.30
|
|
65
|
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
|
Europace
|
2013
|
1.16
|
|
66
|
Diagnostic criteria of broad QRS complex tachycardia: decades of evolution.
|
Europace
|
2010
|
1.13
|
|
67
|
Molecular mechanisms of remodeling in human atrial fibrillation.
|
Cardiovasc Res
|
2002
|
1.12
|
|
68
|
Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
|
Europace
|
2006
|
1.09
|
|
69
|
Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts.
|
Eur Heart J
|
2007
|
1.08
|
|
70
|
Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure.
|
J Nucl Med
|
2007
|
1.08
|
|
71
|
Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.
|
Circulation
|
2004
|
1.07
|
|
72
|
Atrial activation time determined by transthoracic Doppler tissue imaging can be used as an estimate of the total duration of atrial electrical activation.
|
J Am Soc Echocardiogr
|
2005
|
1.06
|
|
73
|
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.
|
Cardiovasc Res
|
2002
|
1.05
|
|
74
|
Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
|
Psychosom Med
|
2007
|
1.05
|
|
75
|
Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve.
|
Circulation
|
2003
|
1.04
|
|
76
|
Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy.
|
Europace
|
2010
|
1.02
|
|
77
|
A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice.
|
Eur Heart J
|
2013
|
1.00
|
|
78
|
Randomized study comparing radiofrequency ablation with cryoablation for the treatment of atrial flutter with emphasis on pain perception.
|
Circulation
|
2003
|
0.99
|
|
79
|
Surgical Ablation for Atrial Fibrillation.
|
N Engl J Med
|
2015
|
0.99
|
|
80
|
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
|
J Cardiovasc Electrophysiol
|
2007
|
0.99
|
|
81
|
International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.
|
J Cardiovasc Electrophysiol
|
2003
|
0.98
|
|
82
|
Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation.
|
Prog Cardiovasc Dis
|
2005
|
0.98
|
|
83
|
Catheter-based cryoablation permanently cures patients with common atrial flutter.
|
Circulation
|
2004
|
0.95
|
|
84
|
Catheter Ablation for Persistent Atrial Fibrillation.
|
N Engl J Med
|
2015
|
0.93
|
|
85
|
I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.
|
J Mol Cell Cardiol
|
2009
|
0.92
|
|
86
|
Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
|
Am J Cardiol
|
2011
|
0.92
|
|
87
|
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).
|
J Hypertens
|
2004
|
0.91
|
|
88
|
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
|
Am Heart J
|
2002
|
0.91
|
|
89
|
The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
|
Card Electrophysiol Rev
|
2003
|
0.89
|
|
90
|
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
|
Am Heart J
|
2006
|
0.89
|
|
91
|
Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging.
|
Eur Radiol
|
2009
|
0.89
|
|
92
|
Aspirin versus vitamin K antagonist treatment guided by transoesophageal echocardiography in patients with atrial fibrillation: a pilot study.
|
Heart
|
2014
|
0.89
|
|
93
|
Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests.
|
J Investig Med
|
2002
|
0.88
|
|
94
|
Dronedarone in patients with congestive heart failure: insights from ATHENA.
|
Eur Heart J
|
2010
|
0.87
|
|
95
|
Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial.
|
Eur J Heart Fail
|
2012
|
0.87
|
|
96
|
Abdominal aortic aneurysm screening during transthoracic echocardiography in an unselected population.
|
J Am Soc Echocardiogr
|
2005
|
0.87
|
|
97
|
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
|
Eur J Heart Fail
|
2012
|
0.86
|
|
98
|
An integrated chronic care program for patients with atrial fibrillation: study protocol and methodology for an ongoing prospective randomised controlled trial.
|
Int J Nurs Stud
|
2010
|
0.86
|
|
99
|
Impact of acute and enduring volume overload on mechanotransduction and cytoskeletal integrity of canine left ventricular myocardium.
|
Am J Physiol Heart Circ Physiol
|
2007
|
0.85
|
|
100
|
Paradoxical increase of stimulus to atrium interval despite His-bundle capture during para-Hisian pacing.
|
Europace
|
2009
|
0.85
|
|
101
|
Incremental value of cardiovascular magnetic resonance over echocardiography in the detection of acute and chronic myocardial infarction.
|
J Cardiovasc Magn Reson
|
2013
|
0.85
|
|
102
|
The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation.
|
Europace
|
2013
|
0.84
|
|
103
|
Decreased impact of post-myocardial infarction depression on cardiac prognosis?
|
J Psychosom Res
|
2006
|
0.83
|
|
104
|
Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
|
Eur J Heart Fail
|
2002
|
0.83
|
|
105
|
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
|
Thromb Haemost
|
2012
|
0.83
|
|
106
|
Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms.
|
Semin Thromb Hemost
|
2009
|
0.83
|
|
107
|
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
|
Eur Heart J
|
2007
|
0.83
|
|
108
|
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.
|
BMC Cardiovasc Disord
|
2005
|
0.83
|
|
109
|
Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
|
Int J Cardiol
|
2005
|
0.83
|
|
110
|
Ventricular remodeling during long-term right ventricular pacing following His bundle ablation.
|
Am J Cardiol
|
2006
|
0.82
|
|
111
|
Why don't we ask patients with coronary heart disease directly how much they have changed after treatment?
|
J Cardiopulm Rehabil
|
2002
|
0.82
|
|
112
|
Microalbuminuria modifies the mortality risk associated with electrocardiographic ST-T segment changes.
|
J Am Coll Cardiol
|
2002
|
0.82
|
|
113
|
Single cryothermia applications of less than five minutes produce permanent cavotricuspid isthmus block in humans.
|
Heart Rhythm
|
2004
|
0.82
|
|
114
|
Statins associated with reduced mortality in patients admitted for congestive heart failure.
|
J Card Fail
|
2006
|
0.82
|
|
115
|
Characteristics, management and prognosis of elderly patients in the Euro Heart Survey on atrial fibrillation.
|
Aging Clin Exp Res
|
2012
|
0.82
|
|
116
|
The atrial fibrillation knowledge scale: development, validation and results.
|
Int J Cardiol
|
2013
|
0.82
|
|
117
|
Catheter-based cryoablation produces permanent bidirectional cavotricuspid isthmus conduction block in dogs.
|
J Interv Card Electrophysiol
|
2002
|
0.81
|
|
118
|
Electrocardiographic predictors of out-of-hospital sudden cardiac arrest in patients with coronary artery disease.
|
Am J Cardiol
|
2012
|
0.81
|
|
119
|
Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.
|
Europace
|
2004
|
0.81
|
|
120
|
Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.
|
Eur J Heart Fail
|
2013
|
0.81
|
|
121
|
Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects.
|
Atherosclerosis
|
2002
|
0.80
|
|
122
|
Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery.
|
Heart Rhythm
|
2007
|
0.79
|
|
123
|
Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.
|
Europace
|
2010
|
0.79
|
|
124
|
Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2004
|
0.78
|
|
125
|
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
|
Circulation
|
2011
|
0.78
|
|
126
|
Vectorcardiography for optimization of stimulation intervals in cardiac resynchronization therapy.
|
J Cardiovasc Transl Res
|
2015
|
0.78
|
|
127
|
Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
|
Eur Heart J
|
2005
|
0.78
|
|
128
|
Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
|
Am Heart J
|
2009
|
0.78
|
|
129
|
Late left ventricular pseudoaneurysm formation following subacute myocardial infarction.
|
Int J Cardiol
|
2005
|
0.78
|
|
130
|
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
|
Am J Cardiol
|
2006
|
0.78
|
|
131
|
Hypothermia for out-of-hospital cardiac arrest survivors: a single-center experience.
|
Am J Emerg Med
|
2007
|
0.78
|
|
132
|
Tropical endomyocardial fibrosis (Davies' disease): case report demonstrating the role of magnetic resonance imaging.
|
Int J Cardiovasc Imaging
|
2004
|
0.77
|
|
133
|
Non-invasive characteristics of atrial fibrillation: the value of Holter recordings for the treatment of AF.
|
Card Electrophysiol Rev
|
2002
|
0.77
|
|
134
|
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
|
Cardiovasc Res
|
2002
|
0.77
|
|
135
|
Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
|
Am J Cardiol
|
2004
|
0.77
|
|
136
|
Vectorcardiography as a tool for easy optimization of cardiac resynchronization therapy in canine left bundle branch block hearts.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.77
|
|
137
|
The role of cardiovascular magnetic resonance imaging and computed tomography angiography in suspected non-ST-elevation myocardial infarction patients: design and rationale of the CARdiovascular Magnetic rEsoNance imaging and computed Tomography Angiography (CARMENTA) trial.
|
Am Heart J
|
2013
|
0.77
|
|
138
|
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
|
J Am Coll Cardiol
|
2006
|
0.77
|
|
139
|
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
|
J Cardiovasc Pharmacol
|
2002
|
0.76
|
|
140
|
Recent advances in drug therapy for atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2003
|
0.76
|
|
141
|
Effects of nifedipine on carotid and femoral arterial wall thickness in previously untreated hypertensive patients.
|
Blood Press Suppl
|
2003
|
0.76
|
|
142
|
Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.76
|
|
143
|
Radiofrequency catheter ablation of idiopathic ventricular tachycardia originating in the main stem of the pulmonary artery.
|
J Cardiovasc Electrophysiol
|
2002
|
0.76
|
|
144
|
Oral anticoagulation and stroke in atrial fibrillation.
|
N Engl J Med
|
2003
|
0.75
|
|
145
|
Guideline adherence in antithrombotic treatment after concomitant ablation surgery in atrial fibrillation patients.
|
Interact Cardiovasc Thorac Surg
|
2013
|
0.75
|
|
146
|
Heart failure, atrial fibrillation, and beta-blockers.
|
Eur Heart J
|
2005
|
0.75
|
|
147
|
Aldosterone levels after angiotensin receptor blocker treatment.
|
Circulation
|
2004
|
0.75
|
|
148
|
Reply to a reader's comment.
|
Am J Cardiol
|
2004
|
0.75
|
|
149
|
Clinical and echocardiographic determinants in bicuspid aortic dilatation: Results from a longitudinal observational study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
150
|
Do non-antiarrhythmic drugs have enough pleiotropic power to reduce atrial fibrillation?
|
Europace
|
2010
|
0.75
|
|
151
|
Letter by van Kimmenade et al regarding article, "urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure".
|
Circulation
|
2010
|
0.75
|
|
152
|
Atrial fibrillatory wall motion and degree of atrial remodeling in patients with atrial fibrillation: a tissue velocity imaging study.
|
J Cardiovasc Electrophysiol
|
2009
|
0.75
|
|
153
|
Detection of ventricular ectopy by a novel miniature electrocardiogram recorder.
|
J Electrocardiol
|
2010
|
0.75
|
|
154
|
Preexcitation and myocardial infarction: conditions with confusing electrocardiographic manifestations.
|
J Electrocardiol
|
2008
|
0.75
|
|
155
|
Non-antiarrhythmic drugs to prevent atrial fibrillation.
|
Heart Rhythm
|
2004
|
0.75
|
|
156
|
QRS aberration during atrial fibrillation at rest and during exercise. Effect of a selective potassium channel blocking agent.
|
J Electrocardiol
|
2002
|
0.75
|
|
157
|
Provocation of silence.
|
Europace
|
2009
|
0.75
|
|
158
|
Rapid pacing results in changes in atrial but not in ventricular refractoriness.
|
Pacing Clin Electrophysiol
|
2002
|
0.75
|
|
159
|
Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes.
|
Sci Rep
|
2017
|
0.75
|
|
160
|
The ABLA-BOX: An In Vitro Module of Hybrid Atrial Fibrillation Ablation.
|
Innovations (Phila)
|
2016
|
0.75
|
|
161
|
Sinus node function after cardiac surgery: is impairment specific for the maze procedure?
|
Int J Cardiol
|
2004
|
0.75
|
|
162
|
Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
163
|
Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
|
Clin Cardiol
|
2014
|
0.75
|
|
164
|
Difference in the relation between urinary albumin excretion and carotid intima-media thickness in nondiabetic and type 2 diabetic subjects.
|
Diabetes Care
|
2002
|
0.75
|
|
165
|
Stroke and bleeding as an endpoint in atrial fibrillation studies.
|
Heart Rhythm
|
2004
|
0.75
|
|
166
|
The fibrillating atrial myocardium visualized: an unexploited source of information.
|
Heart Rhythm
|
2008
|
0.75
|
|
167
|
Rate versus rhythm control in atrial fibrillation.
|
Cardiol Clin
|
2004
|
0.75
|
|
168
|
Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.
|
Ann Noninvasive Electrocardiol
|
2006
|
0.75
|
|
169
|
Reduced ventricular proarrhythmic potential of the novel combined ion-channel blocker AZD1305 versus dofetilide in dogs with remodeled hearts.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.75
|
|
170
|
Serial left-ventricular biopsy sampling using a minimally invasive trans-thoracic approach in adult dogs.
|
Pflugers Arch
|
2007
|
0.75
|